Insulet
PODD
#994
Rank
S$26.86 B
Marketcap
$383.04
Share price
1.62%
Change (1 day)
48.13%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.44 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.98 Billion. In 2023 the company made an earning of S$0.33 Billion, an increase over its 2022 earnings that were of S$57.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.44 B32.39%
2023 S$0.33 B481.9%
2022 S$57.87 M-45.24%
2021 S$0.10 B43.35%
2020 S$73.72 M18.51%
2019 S$62.21 M41.16%
2018 S$44.07 M-711.95%
2017 -S$7.21 Million-56.85%
2016 -S$16.7 Million-79.31%
2015 -S$80.69 Million63.85%
2014 -S$49.25 Million31.04%
2013 -S$37.58 Million-21.96%
2012 -S$48.16 Million
2010 -S$45.93 Million-42.38%
2009 -S$79.72 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$72.31 Million209.75%
2006 -S$23.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$5.18 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.17 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.02 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$23.42 B 5,069.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.10 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.94 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.63 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA